Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
diarrhea
clostridium infections, diarrhea, cdad, clostridium difficile, diarrhea, clostridium difficile-associated diarrhea, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 866285
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.